chr14-47096942-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2
The NM_001113498.3(MDGA2):c.1107C>T(p.Ile369Ile) variant causes a synonymous change. The variant allele was found at a frequency of 0.00331 in 1,613,310 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 21 hom. )
Consequence
MDGA2
NM_001113498.3 synonymous
NM_001113498.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 6.23
Genes affected
MDGA2 (HGNC:19835): (MAM domain containing glycosylphosphatidylinositol anchor 2) Predicted to be involved in regulation of presynapse assembly; regulation of synaptic membrane adhesion; and spinal cord motor neuron differentiation. Predicted to act upstream of or within neuron migration and pattern specification process. Predicted to be located in extracellular region and plasma membrane. Predicted to be active in GABA-ergic synapse and glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.186).
BP6
Variant 14-47096942-G-A is Benign according to our data. Variant chr14-47096942-G-A is described in ClinVar as [Benign]. Clinvar id is 774712.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 21 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00266 AC: 404AN: 151986Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
404
AN:
151986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00277 AC: 690AN: 249030 AF XY: 0.00297 show subpopulations
GnomAD2 exomes
AF:
AC:
690
AN:
249030
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00338 AC: 4932AN: 1461206Hom.: 21 Cov.: 32 AF XY: 0.00331 AC XY: 2407AN XY: 726926 show subpopulations
GnomAD4 exome
AF:
AC:
4932
AN:
1461206
Hom.:
Cov.:
32
AF XY:
AC XY:
2407
AN XY:
726926
Gnomad4 AFR exome
AF:
AC:
20
AN:
33450
Gnomad4 AMR exome
AF:
AC:
81
AN:
44668
Gnomad4 ASJ exome
AF:
AC:
10
AN:
26094
Gnomad4 EAS exome
AF:
AC:
0
AN:
39692
Gnomad4 SAS exome
AF:
AC:
178
AN:
86246
Gnomad4 FIN exome
AF:
AC:
297
AN:
53416
Gnomad4 NFE exome
AF:
AC:
4153
AN:
1111510
Gnomad4 Remaining exome
AF:
AC:
176
AN:
60364
Heterozygous variant carriers
0
270
540
809
1079
1349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00266 AC: 405AN: 152104Hom.: 1 Cov.: 32 AF XY: 0.00295 AC XY: 219AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
405
AN:
152104
Hom.:
Cov.:
32
AF XY:
AC XY:
219
AN XY:
74362
Gnomad4 AFR
AF:
AC:
0.000433338
AN:
0.000433338
Gnomad4 AMR
AF:
AC:
0.00229538
AN:
0.00229538
Gnomad4 ASJ
AF:
AC:
0.000577367
AN:
0.000577367
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.0026971
AN:
0.0026971
Gnomad4 FIN
AF:
AC:
0.00706348
AN:
0.00706348
Gnomad4 NFE
AF:
AC:
0.00381219
AN:
0.00381219
Gnomad4 OTH
AF:
AC:
0.00142315
AN:
0.00142315
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 04, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=98/2
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at